Cortex Pharmaceuticals Inc.: The Irvine drug development...

Cortex Pharmaceuticals Inc.: The Irvine drug development company said it lost $4.7 million, or 19 cents a share, for the fiscal year ended June 30, compared to a net loss of $761,536, or 5 cents a share, for the prior fiscal year. For the fourth quarter, the company reported a net loss of $1.5 million, or 5 cents a share, compared to a net loss of $308,625, or 2 cents a share, for the 1993 quarter. Cortex did not report any sales from products.